Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jason Knight and Yu Zuo.
Jason Knight
Connection Strength
3.857
Yu Zuo
  1. Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight. 2021 08 09; 6(15).
    View in: PubMed
    Score: 0.961
  2. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020 11 18; 12(570).
    View in: PubMed
    Score: 0.911
  3. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020 06 04; 5(11).
    View in: PubMed
    Score: 0.885
  4. Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide. JCI Insight. 2021 09 08; 6(17).
    View in: PubMed
    Score: 0.242
  5. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients. Sci Rep. 2021 01 15; 11(1):1580.
    View in: PubMed
    Score: 0.231
  6. The interplay between neutrophils, complement, and microthrombi in COVID-19. Best Pract Res Clin Rheumatol. 2021 03; 35(1):101661.
    View in: PubMed
    Score: 0.231
  7. Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis. 2021 Feb; 51(2):446-453.
    View in: PubMed
    Score: 0.228
  8. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. J Leukoc Biol. 2021 01; 109(1):67-72.
    View in: PubMed
    Score: 0.056
  9. New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm. JCI Insight. 2020 07 23; 5(14).
    View in: PubMed
    Score: 0.056
  10. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020 06 01; 217(6).
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.